Articles from: papers.ssrn.com
Mashup Score:2
papers.ssrn.comBackground: Thromboembolism and thrombocytopenia have emerged as potential adverse events associated with vaccines against SARS-CoV-2. We compared rates of...
-
Important paper @TheLancet regarding blood clotting risk & #COVID19 infection vs #Pfizer vaccine vs #AstraZeneca vaccine. Highest risk with covid infection similar bw pfizer & AZ (numerically lowest with AZ). Let’s just get #CovidVaccine. https://t.co/pHOEtGnw21 - view on twitter
Mashup Score:1
papers.ssrn.comBackground: Thromboembolism and thrombocytopenia have emerged as potential adverse events associated with vaccines against SARS-CoV-2. We compared rates of...
-
Preprint @TheLancet suggests that AZ & Pfizer had similarly low rates of thrombotic complications. Much lower than those with CoVid infection. Perhaps some international political leaders will come to regret trashing vaccines for political purposes. https://t.co/ADaRZkrE69 https://t.co/ADaRZkrE69 - view on twitter
Mashup Score:852
papers.ssrn.comSafety and Cross-Variant Immunogenicity of a Three-Dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients by Filippo Massa, Marion Cremoni, Alexandre Gerard, Hanen Grabsi, Lory Rogier, Mathilde Blois, Nadia Ben Hassen, Matthieu Rouleau, Susana Barbosa, Emanuela Martinuzzi, Julien… - 1 week
Mashup Score:852
Background: The immunogenicity of a two-dose mRNA COVID-19 vaccine regimen is low in kidney transplant (KT) recipients. We report the first complete...
-
@vass_vassiliou @AnastasiaSMihai @hvanspall @iamritu @mmamas1973 @kidneydoc101 Important topic. More pre-print data from 🇫🇷 below 💉💉💉 https://t.co/5tW0BcntBN https://t.co/5tW0BcntBN - view on twitter
Mashup Score:739
papers.ssrn.comSafety and Cross-Variant Immunogenicity of a Three-Dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients by Filippo Massa, Marion Cremoni, Alexandre Gerard, Hanen Grabsi, Lory Rogier, Mathilde Blois, Nadia Ben Hassen, Matthieu Rouleau, Susana Barbosa, Emanuela Martinuzzi, Julien… - 1 week
Mashup Score:739
Background: The immunogenicity of a two-dose mRNA COVID-19 vaccine regimen is low in kidney transplant (KT) recipients. We report the first complete...
-
A new (preprint) study in 61 people w/ kidney transplants and 3-doses of mRNA vaccines. It's safe and it helps with both antibody response, T cells, and vs variants https://t.co/r4PfkSwctk https://t.co/r4PfkSwctk - view on twitter
Mashup Score:1426
papers.ssrn.comPost-Vaccination Symptomatic SARS-CoV-2 Infections are Minimal and Non-Serious: An Observational Multicenter Indian Cohort Study of 28342 Healthcare Workers by Raju Vaishya, Anupam Sibal, Arpita Malani, Sujoy Kar, Hari Prasad K., Kiran SV, Sangita Reddy, Shobana Kamineni, Suneeta Reddy, Preetha … - 2 weeks
Mashup Score:1426
Background: The healthcare workers (HCWs) have been on the frontline in combating the pandemic and were prioritized for vaccination when COVID-19 vaccines...
-
On "breakthrough" infections post-vaccination in India. ~5% of >28,000 healthcare workers with mild symptoms, 0.29% led to hospitalization, no deaths; they were 83% suppressed by AZ and Bharat Biotech vaccines https://t.co/YZKLAmxZMZ - view on twitter
Mashup Score:80
papers.ssrn.comComparison of the Immunogenicity of BNT162b2 and CoronaVac COVID-19 Vaccines in Hong Kong: An Observational Cohort Study by Chris Ka Pun Mok, Carolyn A. Cohen, Samuel M.S. Cheng, Chunke Chen, Kin-On Kwok, Karen Yiu, Tat-On Chan, Maireid Bull, Kwun Cheung Ling, Zixi Dai, Susanna S. Ng, Grace C.Y…. - 2 weeks
Mashup Score:80
Background: COVID-19 vaccination programs are ongoing world-over using a wide array of vaccines. The performance of vaccines has been evaluated for...
-
Independent replication for these differences via head-to-head comparison for immune response https://t.co/rD3KnMUk7F https://t.co/rD3KnMUk7F - view on twitter
Mashup Score:9
papers.ssrn.comThe World Health Assembly will be holding an unprecedented second meeting this year in November, with only a single item on the agenda –...
-
As the Working Group on Strengthening @WHO Preparedness & Response meets to assess the benefits of a #PandemicTreaty, I join Dame Barbara Stocking & @BenjaminMMeier in examining the necessary norms, governance & compliance mechanisms in #GlobalHealthLaw https://t.co/vsO2CHA5hJ - view on twitter
Mashup Score:6
papers.ssrn.comBrand-name prescription drugs are sold at extremely high prices in the US because patents and other market exclusivities provided by the government allow...
-
My recent @HastingsLJ article #GenericButExpensive (with @PORTAL_Research @akesselheim @frazer_tessema) addresses the problems associated with niche drug markets in the generic sector. Nonprofit manufacturers like @CivicaRx are part of the solution. https://t.co/3iXx1lH6Cr https://t.co/3iXx1lH6Cr - view on twitter
More coverage:
#genericbutexpensive
Mashup Score:22
papers.ssrn.comSince the first case was reported to the World Health Organisation in December 2019, SARS-CoV-2 (COVID-19) has caused social and economic devastation on a...
-
🚨HOT OFF THE PRE-PRINT PRESSES🚨 And coming in swiftly after yesterday’s announcements, here’s our paper on the human rights, public health ethics, & digital ethics implications of COVID-19 #VaccinePassports https://t.co/Kznq6menZ3 w/ @EmmieHine @RosariaTaddeo @Floridi 🧵… - view on twitter
More coverage:
#vaccinepassports
Background: Thromboembolism and thrombocytopenia have emerged as potential adverse events associated with vaccines against SARS-CoV-2. We compared rates of...
Important paper @TheLancet. Highest risk of blood clotting from #Covid infection. Pretty much equal risk of blood clotting from #Pfizer vaccine and #AstraZeneca vaccine. https://t.co/pHOEtGnw21 - view on twitter